Canadian Markets open in 2 hrs 57 mins

Ceapro Inc. (CZO.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.830.00 (0.00%)
At close: 3:57PM EDT
Full screen
Previous Close0.83
Open0.82
Bid0.82 x
Ask0.85 x
Day's Range0.82 - 0.85
52 Week Range0.82 - 2.37
Volume23,620
Avg. Volume134,046
Market Cap62.54M
Beta4.45
PE Ratio (TTM)25.15
EPS (TTM)0.03
Earnings DateAug 22, 2017 - Aug 28, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks Small Cap Researchlast month

    CZO In-line 4Q:17 Revenues; PGX Advancing

    On May 17, 2017, Ceapro Inc. (CZO.V) posted financial and operational results and filed interim statements for the first quarter of 2017.  Revenues during the period were $3.2 million and matched our estimates.  Due to lower gross margin and higher operating expenses, earnings of $18 thousand or $0.00 per share fell below our predictions of $0.9 million or $0.01 per share.  These results compare to first quarter 2016 revenues of $4.1 million and per share earnings of $0.02.

  • Marketwired2 months ago

    Ceapro Announces Results of 2017 Shareholders' Meeting

    Ceapro Inc. , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that all proposed Directors, ...

  • Marketwired2 months ago

    Ceapro Inc. Announces its First Major Milestones with its PGX Enabling Technology

    Ceapro Inc. , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today provided an update of the Company's ...